Awareness and consumption of folate-fortified foods by women of childbearing age in Western Australia

Public Health Nutrition

Volumn 10, Issue 10, 2007, Pages 989-995

  Oddy, W H ^a,b   Miller, M ^a   Payne, J M ^a   Serna, J ^a   Bower, C I ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c Western Australian Birth Defects Registry   (Australia)

Author keywords

Folate; Folic acid; Fortification; Neural tube defects

Indexed keywords

FOLIC ACID;

ARTICLE; AUSTRALIA; AWARENESS; BIRTH DEFECT; BREAD; CEREAL; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FOOD PACKAGING; GESTATIONAL AGE; HUMAN; MILK; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; SPINA BIFIDA;

ADULT; AWARENESS; FEMALE; FOLIC ACID; FOOD LABELING; FOOD, FORTIFIED; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; QUESTIONNAIRES; SPINAL DYSRAPHISM; VITAMIN B COMPLEX; WESTERN AUSTRALIA;

EID: 34548379131     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980007796295     Document Type: Article

References (32)

1. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins to prevent neural tube defects. Cochrane Database Systematic Review 2001; (3): CD001056.
2. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA: Journal of the American Medical Association 1993; 269: 1257-61.
3. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. American Journal of Medical Genetics 1995; 59: 536-45.
4. Milunsky A, Jick H, Jick SS, Bruell CL. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA: Journal of the American Medical Association 1989; 262: 2847-52.
5. Friel JK, Freckler M, Fraser FC. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. American Journal of Medical Genetics 1995; 55: 195-99.
6. Bower C, Stanley FJ. Dietary folate as a risk factor for neuraltube defects: evidence from a case-control study in Western Australia. Medical Journal of Australia 1989; 150: 613-19.
7. NH&MRC. Revised statement on the relationship between dietary folic acid and neural tube defects such as spina bifida. Journal of Paediatrics and Child Health 1994; 30: 476-7.
8. Bower C, Blum L, Ng ML, Irvin C, Kurinczuk J. Folate. Preventing neural tube defects. The pharmacist's contribution. Australian Pharmacist 1995; 14: 367-71.
9. Bower C, Blum L, Watson C, Stanley FJ. Folate and the prevention of neural tube defects: evaluation of a health promotion project in Western Australia. Health Promotion International 1996; 11: 177-87.
10. Bower C, Blum L, O'Daly K, Higgins C, Loutsky F, Kosky C. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992-1995. Australian and New Zealand Journal of Public Health 1997; 21: 716-21.
11. Bower C, Knowles S, Nicol D. Changes in folate supplementation, and in serum and red cell folate levels in antenatal patients over the course of a health promotion project for the prevention of neural tube defects. Australian & New Zealand Journal Obstetrics & Gynaecology 1997; 37: 267-71.
12. Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. Pre-pregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake. Medical Journal of Australia 1995; 162: 403-6.
13. Abraham B, Webb K. Interim Evaluation of the Voluntary Folate Fortification Policy. Canberra: Australian Food and Nutrition Monitoring Unit, 2001.
14. Bower C, Ryan A, Rudy E, Miller M. Trends in neural tube defects in Western Australia. Australian and New Zealand Journal of Public Health 2002; 346: 725-30.
15. Bower C, Miller M, Payne J, Serna P, de Klerk NH, Stanley FJ. Folate promotion in Western Australia and the prevention of neural tube defects. Australian and New Zealand Journal of Public Health 2004; 28: 458-64.
16. Werler MM, Bower C, Payne J, Serna P. Findings on potential teratogens from a case-control study in Western Australia. Australian & New Zealand Journal Obstetrics & Gynaecology 2003; 43: 443-7.
17. Gee V. Perinatal Statistics in Western Australia. Fourteenth Annual Report of the Western Australian Midwives' Notification System 1996. Statistical Series No. 56. Perth: Health Department of Western Australia, May 1998.
18. Lawrence MA, Rutishauser IHE, Lewis JL. A practical approach to monitoring nutrient supplement intake of Australian adults. Australian Journal of Nutrition and Dietetics 2001; 58: 98-103.
19. Smith A, Kellett E, Schmerlaib Y. The Australian Guide to Healthy Eating: Background Information for Nutrition Educators. Canberra: Commonwealth of Australia, 1998.
20. Bower CI, Miller M, Payne JM, Serna P. Promotion of folate for the prevention of neural tube defects: who benefits? Paediatric and Perinatal Epidemiology 2005; 19: 435-44.
21. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA: Journal of the American Medical Association 2001; 285: 2981-6.
22. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002; 360: 2047-8.
23. Egger G, Donovan RJ, Spark R. Health Promotion, Strategies and Methods, 2nd ed. Sydney: McGraw-Hill, 2005.
24. Watson M, Watson L, Bell R, Halliday J. The increasing knowledge of the role of periconceptional folate in Victorian women of child-bearing age: follow-up of a randomised community intervention trial. Australian and New Zealand Journal of Public Health 2001; 25: 389-95.
25. Watson M, Watson L. An evaluation of the impact of the folate and neural tube defects health claim pilot. Australian Journal of Nutrition and Dietetics 2001; 58: 236-41.
26. Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. British Journal of Obstetrics and Gynaecology 2004; 111: 399-408.
27. Bower C, Eades S, Payne J, D'Antoine H, Stanley FJ. Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations. Paediatric and Perinatal Epidemiology 2004; 18: 277-80.
28. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, et al. Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Research 2000; 60: 6935-41.
29. Signore C, Mills JL, Cox C, Trumble AC. Effects of folic acid fortification on twin gestation rates. Obstetrics and Gynecology 2005; 105: 757-62.
30. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy and Childbirth 2004; 4: 20.
31. Hickling S, Hung J, Knuiman M, Jamrozik K, McQuillan B, Beilby J, et al. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study. Journal of Epidemiology and Community Health 2005; 59: 371-6.
32. Lopez-Camelo JS, Orioli IM, da Graca Dutra M, Nazer-Herrera J, Rivera N, Ojeda ME, et al. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. American Journal of Medical Genetics 2005; 135: 120-5.